National Institutes of Health OLAO
FederalMD
Posted
Oct 28, 2026
Nov 9, 2026
Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance RFP
This active presolicitation is an NIH notice of intent to award a noncompetitive contract for regulatory stability testing of ManNAc drug product from Campaigns 5 and 6. NHGRI took over the required stability-testing program for 48 kg of donated clinical-grade product previously tested by Alcami Corporation, which is intended for upcoming clinical trials. Interested parties may submit capability and proposal information by November 9, 2026 at 9:00 AM Eastern; the notice is not a request for competitive proposals.
